Intuitive Surgical (NASDAQ: ISRG) SVP gets stock units and tax withholdings

Rhea-AI Filing Summary

Intuitive Surgical SVP Iman Jeddi reported multiple equity compensation transactions dated February 26, 2026. He was granted 2,793 performance stock units originally awarded on February 28, 2023, after the Compensation Committee confirmed performance goals were achieved; these PSUs vest on February 28, 2026, subject to continued service. He also received a new grant of 4,480 restricted stock units that vest 25% annually over four years. Previously granted RSUs converted into 1,622 and 687 shares of common stock on a one-for-one basis as they vested, with 631 and 341 shares of common stock withheld at a price of $506.17 per share to cover statutory tax obligations. Following these transactions, he holds direct common stock and derivative awards, and 26,649 additional common shares are held indirectly by a trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jeddi Iman

(Last) (First) (Middle)

1020 KIFER ROAD

(Street)

SUNNYVALE CA 94086

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INTUITIVE SURGICAL INC [ ISRG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & GM da Vinci Platforms &

3. Date of Earliest Transaction (Month/Day/Year)
02/26/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/26/2026		M(1)		1,622	A	$0.0	2,207	D
Common Stock	02/26/2026		F(1)		631	D	$506.17	1,576	D
Common Stock	02/26/2026		M(1)		687	A	$0.0	2,263	D
Common Stock	02/26/2026		F(1)		341	D	$506.17	1,922	D
Common Stock								26,649	I	by Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Units - 2-28-2023	$0.0	02/26/2026		A		2,793		(2)	(2)	Common Stock	2,793	$0.0	8,378	D
Restricted Stock Units - 2-26-2024	$0.0	02/26/2026		M			1,622	(3)	(3)	Common Stock	1,622	$0.0	3,243	D
Restricted Stock Units - 2-26-2025	$0.0	02/26/2026		M			687	(3)	(3)	Common Stock	687	$0.0	2,059	D
Restricted Stock Units - 2-26-2026	$0.0	02/26/2026		A		4,480		(3)	(3)	Common Stock	4,480	$0.0	4,480	D

Explanation of Responses:

1. RSUs vest 25% per year over a four year period, commencing on the first anniversary of the grant date. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.

2. Represents performance stock units ("PSUs") initially granted to the Reporting Person on February 28, 2023 subject to achievement of certain performance metrics. The performance criteria for the PSUs reported herein have been achieved, as determined by the Compensation Committee of the Issuer. The PSUs reported herein vest on February 28, 2026, the third anniversary of the grant date, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

3. Each RSU granted represents a contingent right to receive one share of Intuitive Surgical common stock. The grant vests 25% on the first anniversary of the date of grant and annually thereafter, over a four year period.

	By: Stephanie Lim-Ignacio For: Jeddi, Iman	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Intuitive Surgical (ISRG) executive Iman Jeddi report in this Form 4?

Iman Jeddi reported new grants and vesting of equity awards, including performance stock units and restricted stock units, along with related tax share withholdings. These transactions reflect routine executive compensation activity rather than open-market stock purchases or discretionary sales.

How many performance stock units did Iman Jeddi report for Intuitive Surgical (ISRG)?

He reported 2,793 performance stock units initially granted on February 28, 2023. The Compensation Committee determined the performance criteria were achieved, and these units are scheduled to vest on February 28, 2026, if he remains in continuous service with Intuitive Surgical.

What restricted stock unit grants did Iman Jeddi receive from Intuitive Surgical (ISRG)?

He received a grant of 4,480 restricted stock units that vest 25% on the first anniversary of the grant date and annually thereafter over four years. Each RSU represents a contingent right to receive one share of Intuitive Surgical common stock upon vesting.

What do the tax-withholding share dispositions mean in this Intuitive Surgical (ISRG) filing?

The filing shows dispositions of 631 and 341 common shares at $506.17 per share coded as tax-withholding transactions. These shares were withheld to satisfy statutory tax obligations on vested RSUs, rather than being sold in open-market transactions initiated by the executive.

How do the RSUs in this Intuitive Surgical (ISRG) Form 4 vest and convert?

Each restricted stock unit converts into one share of common stock on the vesting date. The RSUs vest 25% per year over four years, starting one year after the grant date, with some shares withheld to cover required tax withholding obligations.

What indirect Intuitive Surgical (ISRG) holdings are reported for Iman Jeddi?

The Form 4 notes 26,649 shares of Intuitive Surgical common stock held indirectly by a trust. This is reported as indirect ownership "by Trust," indicating an additional position associated with the reporting person separate from his directly held shares and awards.